Evidence map›Paper›PMID 29853912›Full record

ArticleStem cells international2018

Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration.

Ilaria Roato, Dimas Carolina Belisario, Mara Compagno, Laura Verderio, Anna Sighinolfi, Federico Mussano, Tullio Genova, Francesca Veneziano, Gianni Pertici, Giuseppe Perale and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.International journal of molecular sciences · 2024
    Review
  5. The Use of Stromal Vascular Fraction in Long Bone Defect Healing in Sheep.Animals : an open access journal from MDPI · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Advances on Bone Substitutes through 3D Bioprinting.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ilaria RoatoCenter for Research and Medical Studies, A.O.U. Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0003-3029-4743
Dimas Carolina BelisarioCenter for Research and Medical Studies, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Mara CompagnoCenter for Research and Medical Studies, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Laura VerderioDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico of Milan, Milan, Italy.
Anna SighinolfiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico of Milan, Milan, Italy.
Federico MussanoCIR Dental School, Department of Surgical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-5800-0749
Tullio GenovaCIR Dental School, Department of Surgical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7824-8389
Francesca VenezianoPathology Unit, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Gianni PerticiIndustrie Biomediche Insubri SA, Mezzovico-Vira, Switzerland.
Giuseppe PeraleIndustrie Biomediche Insubri SA, Mezzovico-Vira, Switzerland.
Riccardo FerraciniDepartment of Surgical Sciences (DISC), Orthopaedic Clinic, IRCCS A.O.U. San Martino, Genoa, Italy.
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITPolitecnico di Milano · ITUniversity of Turin · ITOspedale Policlinico San Martino · ITUniversity of Applied Sciences and Arts of Southern Switzerland · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipose tissue-derived stem cells (ASCs) are a promising tool for the treatment of bone diseases or skeletal lesions, thanks to their ability to potentially repair damaged tissue. One of the major limitations of ASCs is represented by the necessity to be isolated and expanded through

Identifiers

PMID29853912
PMCPMC5949175
OpenAlexW2799329169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.